Fairvalue-Calculator Fairvalue-Calculator
EN DE

YungShin Global Holding (3705) Fair Value & Analysis

Healthcare · TW · Market cap 15.2B TWD

Price54.10 TWD
Fair Value72.75 TWD
Upside+34.5%
Quality86/100
Evidence: Medium Range 50.20 TWD – 90.94 TWD

Fair value as of: Jun 24, 2026

Analysis

YungShin Global Holding (3705) currently trades at 54.10 TWD, while our model-based Fair Value estimate is 72.75 TWD — implying the stock looks roughly 34.5% undervalued today. We read business quality at 86/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

YungShin Global Holding Corporation, through its subsidiaries, engages in investing, manufacturing, and sale of medicines, veterinary drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, Mainland China, and Japan. YungShin Global Holding Corporation was founded in 1952 and is based in Taipei, Taiwan.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is YungShin Global Holding (3705) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 72.75 TWD versus a price of 54.10 TWD — about +34% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 3705?
Our 21-model fair value for YungShin Global Holding is 72.75 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 54.10 TWD.
What is the quality score of 3705?
YungShin Global Holding has a Quality Score of 86/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.